Treatment related observations in solid tissues, fibroblast cultured and amniotic fluid cells of type II glycogenosis, Hurler disease and metachromatic leukodystrophy.
D001803:Blood Transfusion; D002478:Cells, Cultured; D002675:Child, Preschool; D003593:Cytoplasm / Q000032:analysis / Q000201:enzymology; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D005959:Glucosidases / Q000172:deficiency; D006003:Glycogen / Q000032:analysis; D006008:Glycogen Storage Disease / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D006801:Humans; D007223:Infant; D007966:Leukodystrophy, Metachromatic / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology*; D008099:Liver / Q000032:analysis; D008247:Lysosomes / Q000032:analysis / Q000201:enzymology; D008297:Male; D008854:Microscopy, Electron; D008059:Mucopolysaccharidosis I / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology*; D016532:Mucopolysaccharidosis II / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology*; D011296:Prenatal Diagnosis; D012867:Skin / Q000201:enzymology; D013429:Sulfatases / Q000627:therapeutic use
D006003:Glycogen; D013429:Sulfatases; D005959:Glucosidases; D004837:Epinephrine